> top > projects > sentences > docs > PubMed:16037491 > annotations
sentences Home  

PubMed:16037491 JSONTXT 67 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-122 Sentence denotes Patients with unsolved congenital disorders of glycosylation type II can be subdivided in six distinct biochemical groups.
T1 0-122 Sentence denotes Patients with unsolved congenital disorders of glycosylation type II can be subdivided in six distinct biochemical groups.
T1 0-122 Sentence denotes Patients with unsolved congenital disorders of glycosylation type II can be subdivided in six distinct biochemical groups.
TextSentencer_T2 123-279 Sentence denotes Defects in the biosynthesis of N- and core 1 O-glycans may be found by isoelectric focusing (IEF) of plasma transferrin and apolipoprotein C-III (apoC-III).
T2 123-279 Sentence denotes Defects in the biosynthesis of N- and core 1 O-glycans may be found by isoelectric focusing (IEF) of plasma transferrin and apolipoprotein C-III (apoC-III).
T2 123-279 Sentence denotes Defects in the biosynthesis of N- and core 1 O-glycans may be found by isoelectric focusing (IEF) of plasma transferrin and apolipoprotein C-III (apoC-III).
TextSentencer_T3 280-521 Sentence denotes We hypothesized that IEF of transferrin and apoC-III in combination with sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) of apoC-III may provide a classification for congenital disorders of glycosylation (CDG) patients.
T3 280-521 Sentence denotes We hypothesized that IEF of transferrin and apoC-III in combination with sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) of apoC-III may provide a classification for congenital disorders of glycosylation (CDG) patients.
T3 280-521 Sentence denotes We hypothesized that IEF of transferrin and apoC-III in combination with sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) of apoC-III may provide a classification for congenital disorders of glycosylation (CDG) patients.
TextSentencer_T4 522-646 Sentence denotes We analyzed plasma from 22 patients with eight different and well-characterized CDG subtypes and 19 cases with unsolved CDG.
T4 522-646 Sentence denotes We analyzed plasma from 22 patients with eight different and well-characterized CDG subtypes and 19 cases with unsolved CDG.
T4 522-646 Sentence denotes We analyzed plasma from 22 patients with eight different and well-characterized CDG subtypes and 19 cases with unsolved CDG.
TextSentencer_T5 647-782 Sentence denotes Transferrin IEF (TIEF) has been used to distinguish between N-glycan assembly (type 1 profile) and processing (type 2 profile) defects.
T5 647-782 Sentence denotes Transferrin IEF (TIEF) has been used to distinguish between N-glycan assembly (type 1 profile) and processing (type 2 profile) defects.
T5 647-782 Sentence denotes Transferrin IEF (TIEF) has been used to distinguish between N-glycan assembly (type 1 profile) and processing (type 2 profile) defects.
TextSentencer_T6 783-840 Sentence denotes We differentiated two different CDG type 2 TIEF profiles:
T6 783-840 Sentence denotes We differentiated two different CDG type 2 TIEF profiles:
T6 783-840 Sentence denotes We differentiated two different CDG type 2 TIEF profiles:
TextSentencer_T7 841-1027 Sentence denotes The "asialo profile" characterized by elevated levels of asialo- and monosialotransferrin and the "disialo profile" characterized by increased levels of disialo- and trisialotransferrin.
T7 841-1027 Sentence denotes The "asialo profile" characterized by elevated levels of asialo- and monosialotransferrin and the "disialo profile" characterized by increased levels of disialo- and trisialotransferrin.
T7 841-1027 Sentence denotes The "asialo profile" characterized by elevated levels of asialo- and monosialotransferrin and the "disialo profile" characterized by increased levels of disialo- and trisialotransferrin.
TextSentencer_T8 1028-1111 Sentence denotes ApoC-III IEF gave two abnormal profiles ("apoC-III(0)" and "apoC-III(1)" profiles).
T8 1028-1111 Sentence denotes ApoC-III IEF gave two abnormal profiles ("apoC-III(0)" and "apoC-III(1)" profiles).
T8 1028-1111 Sentence denotes ApoC-III IEF gave two abnormal profiles ("apoC-III(0)" and "apoC-III(1)" profiles).
TextSentencer_T9 1112-1252 Sentence denotes The results for the eight established CDG forms exactly matched the theoretical expectations, providing a validation for the study approach.
T9 1112-1252 Sentence denotes The results for the eight established CDG forms exactly matched the theoretical expectations, providing a validation for the study approach.
T9 1112-1252 Sentence denotes The results for the eight established CDG forms exactly matched the theoretical expectations, providing a validation for the study approach.
TextSentencer_T10 1253-1407 Sentence denotes The combination of the three electrophoretic techniques was not additionally informative for the CDG-Ix patients as they had normal apoC-III IEF patterns.
T10 1253-1407 Sentence denotes The combination of the three electrophoretic techniques was not additionally informative for the CDG-Ix patients as they had normal apoC-III IEF patterns.
T10 1253-1407 Sentence denotes The combination of the three electrophoretic techniques was not additionally informative for the CDG-Ix patients as they had normal apoC-III IEF patterns.
TextSentencer_T11 1408-1497 Sentence denotes However, the CDG-IIx patients could be further subdivided into six biochemical subgroups.
T11 1408-1497 Sentence denotes However, the CDG-IIx patients could be further subdivided into six biochemical subgroups.
T11 1408-1497 Sentence denotes However, the CDG-IIx patients could be further subdivided into six biochemical subgroups.
TextSentencer_T12 1498-1736 Sentence denotes The robustness of the methodology was supported by the fact that three patients with similar clinical features ended in the same subgroup and that another patient, classified in the "CDG-IIe subgroup," turned out to have a similar defect.
T12 1498-1736 Sentence denotes The robustness of the methodology was supported by the fact that three patients with similar clinical features ended in the same subgroup and that another patient, classified in the "CDG-IIe subgroup," turned out to have a similar defect.
T12 1498-1736 Sentence denotes The robustness of the methodology was supported by the fact that three patients with similar clinical features ended in the same subgroup and that another patient, classified in the "CDG-IIe subgroup," turned out to have a similar defect.
TextSentencer_T13 1737-1922 Sentence denotes Dividing the CDG-IIx patients in six subgroups narrows down drastically the options of the primary defect in each of the subgroups and will be helpful to define new CDG type II defects.
T13 1737-1922 Sentence denotes Dividing the CDG-IIx patients in six subgroups narrows down drastically the options of the primary defect in each of the subgroups and will be helpful to define new CDG type II defects.
T13 1737-1922 Sentence denotes Dividing the CDG-IIx patients in six subgroups narrows down drastically the options of the primary defect in each of the subgroups and will be helpful to define new CDG type II defects.